+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06680934

Registry Study for People With Hearing Loss Linked to CABP2 Gene Changes

Led by University Medical Center Goettingen · Updated on 2026-01-27

100

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are collecting detailed information about individuals with hearing loss caused by genetic changes in the CABP2 gene. This observational study aims to support a natural history study by gathering genetic and clinical data to better understand CABP2-associated hearing impairment. The study is conducted under ethical guidelines and has approval from the Ethics Committee of the University Medical Center Goettingen. Participants in this registry undergo genetic testing and hearing assessments, including pure-tone and speech audiometry, which are the main diagnostic tests being studied. Secondary tests such as otoacoustic emission thresholds and auditory brainstem responses may also be collected. The study is available in both German and English to accommodate participants. During the study, participants provide consent for hearing tests and genetic information to be recorded and analyzed over a one-year period. Researchers monitor hearing function and genetic data to understand the progression and characteristics of CABP2-related hearing loss. Participation involves providing clinical and molecular genetic information to help support future research and treatment strategies.

CONDITIONS

Brief Title

CABP2 Patient Registry and Natural History Study

Research Team

B

Barbara Vona, PhD

T

Tobias Moser, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here